Recon: China approves Pfizer's COVID drug Paxlovid; Biogen, other drugmakers respond to CMS' coverage proposal for amyloid-targeted Alzheimer's drugs – Regulatory Focus

Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 14 February 2022 | By Joanne S. Eglovitch 

 
Regulatory Focus newsletters

All the biggest regulatory news and happenings.
 
 
Regulatory Affairs Professionals Society (RAPS)
5635 Fishers Lane, Suite 400
Rockville, Maryland 20852
© 2022
Regulatory Affairs Professionals Society.
 

source